Lipid nanoparticle reagents

The CD34+ HSC LNP kit is an LNP reagent mix optimized for the delivery of mRNA or Cas9 mRNA/sgRNA into CD34+ HSCs. This reagent enables researchers to establish a clinically relevant and scalable method at the discovery and preclinical scale for ex vivo gene delivery and editing. CD34+ HSC LNP kit offers the following benefits:

GenVoy-ILM™ reagents are LNP reagents that enable the production of RNA-LNPs using the NanoAssemblr™ Ignite™ and Ignite+™ instruments. The resulting LNPs formed by mixing GenVoy-ILM™ and nucleic acids using Ignite™ and Ignite+™ instruments feature a homogeneous core structure. This reagent has been designed to:

GenVoy-ILM™ T cell Kit for mRNA is a lipid nanoparticle (LNP) reagent mix optimized for the delivery of mRNA or CRISPR Cas9 mRNA with gRNA into human primary T cells using LNPs prepared on the NanoAssemblr™ Spark™ and Ignite™ systems.

Hepato9 mRNA kit is a lipid nanoparticle (LNP) reagent that enables the rapid production of RNA-LNPs using the NanoAssemblr™ Spark™ instrument and is optimized for the in vitro delivery of these nanoparticles.

Neuro9 siRNA kits are lipid nanoparticle (LNP) reagents that enable the production of siRNA-LNPs using the NanoAssemblr™ Spark™ instrument. siRNA-LNP generated using the Neuro9 siRNA transfection kit are optimized for the delivery of these nanoparticles into rat neurons.

The RNA delivery LNP kit for the NanoAssemblr™ Ignite™ and Ignite+™ systems offers ready–to–use ionizable lipid mix and buffers to fast-track payload screening and RNA drug delivery validation, progressing lead candidates quickly through preclinical studies accelerating clinical evaluation.